Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia.

PubWeight™: 1.57‹?› | Rank: Top 4%

🔗 View Article (PMC 4014804)

Published in Genome Biol on September 24, 2013

Authors

Jessica Nordlund, Christofer L Bäcklin, Per Wahlberg, Stephan Busche, Eva C Berglund, Maija-Leena Eloranta, Trond Flaegstad, Erik Forestier, Britt-Marie Frost, Arja Harila-Saari, Mats Heyman, Olafur G Jónsson, Rolf Larsson, Josefine Palle, Lars Rönnblom, Kjeld Schmiegelow, Daniel Sinnett, Stefan Söderhäll, Tomi Pastinen, Mats G Gustafsson, Gudmar Lönnerholm, Ann-Christine Syvänen

Articles citing this

Comprehensive analysis of DNA methylation data with RnBeads. Nat Methods (2014) 2.03

The mutational landscape in pediatric acute lymphoblastic leukemia deciphered by whole genome sequencing. Hum Mutat (2015) 1.46

MethylSig: a whole genome DNA methylation analysis pipeline. Bioinformatics (2014) 1.22

Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells. Cell (2016) 1.10

Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation. Haematologica (2015) 0.89

Genome-wide DNA methylation analysis reveals estrogen-mediated epigenetic repression of metallothionein-1 gene cluster in breast cancer. Clin Epigenetics (2015) 0.88

Modeling DNA methylation dynamics with approaches from phylogenetics. Bioinformatics (2014) 0.86

Epigenetic deregulation in pediatric acute lymphoblastic leukemia. Epigenetics (2014) 0.86

Epigenetic remodeling in B-cell acute lymphoblastic leukemia occurs in two tracks and employs embryonic stem cell-like signatures. Nucleic Acids Res (2015) 0.85

DNA methylation-based subtype prediction for pediatric acute lymphoblastic leukemia. Clin Epigenetics (2015) 0.85

Whole genome DNA methylation signature of HER2-positive breast cancer. Epigenetics (2014) 0.83

Epigenetic modifications in pediatric acute lymphoblastic leukemia. Front Pediatr (2014) 0.82

On the potential of models for location and scale for genome-wide DNA methylation data. BMC Bioinformatics (2014) 0.81

Increased DNA methylation variability in type 1 diabetes across three immune effector cell types. Nat Commun (2016) 0.80

Non-CG DNA methylation is a biomarker for assessing endodermal differentiation capacity in pluripotent stem cells. Nat Commun (2016) 0.79

Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia. Epigenetics (2015) 0.78

LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19. Haematologica (2016) 0.78

PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia. Haematologica (2015) 0.78

CopyNumber450kCancer: baseline correction for accurate copy number calling from the 450k methylation array. Bioinformatics (2015) 0.77

DNA methylation as a potential mediator of environmental risks in the development of childhood acute lymphoblastic leukemia. Epigenomics (2016) 0.77

Arachidonic and oleic acid exert distinct effects on the DNA methylome. Epigenetics (2016) 0.77

Validation of DNA methylation to predict outcome in acute myeloid leukemia by use of xMELP. Clin Chem (2014) 0.77

An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells. Breast Cancer Res (2016) 0.76

A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia. JCI Insight (2016) 0.76

Bioinformatic description of immunotherapy targets for pediatric T-cell leukemia and the impact of normal gene sets used for comparison. Front Oncol (2014) 0.76

Pediatric cancer epigenome and the influence of folate. Epigenomics (2015) 0.75

The Role of Histone Protein Modifications and Mutations in Histone Modifiers in Pediatric B-Cell Progenitor Acute Lymphoblastic Leukemia. Cancers (Basel) (2017) 0.75

Genome-wide analysis of differential transcriptional and epigenetic variability across human immune cell types. Genome Biol (2017) 0.75

Epigenetic changes as prognostic predictors in endometrial carcinomas. Epigenetics (2016) 0.75

The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia. PLoS One (2016) 0.75

DNA Methylation at the Neonatal State and at the Time of Diagnosis: Preliminary Support for an Association with the Estrogen Receptor 1, Gamma-Aminobutyric Acid B Receptor 1, and Myelin Oligodendrocyte Glycoprotein in Female Adolescent Patients with OCD. Front Psychiatry (2016) 0.75

SPlinted Ligation Adapter Tagging (SPLAT), a novel library preparation method for whole genome bisulphite sequencing. Nucleic Acids Res (2016) 0.75

Epigenetic modification and preliminary investigation of the mechanism of the immune evasion of HL-60 cells. Mol Med Rep (2015) 0.75

DNA methylation landscape of ocular tissue relative to matched peripheral blood. Sci Rep (2017) 0.75

Integration of DNA methylation and gene transcription across nineteen cell types reveals cell type-specific and genomic region-dependent regulatory patterns. Sci Rep (2017) 0.75

Patterns of DNMT1 Promoter Methylation in Patients with Acute Lymphoblastic Leukemia. Int J Hematol Oncol Stem Cell Res (2017) 0.75

Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach. Oncotarget (2017) 0.75

Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma. Acta Neuropathol (2017) 0.75

GATA2 regulates the erythropoietin receptor in t(12;21) ALL. Oncotarget (2017) 0.75

Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles. J Hematol Oncol (2017) 0.75

Articles cited by this

Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88

Mapping and analysis of chromatin state dynamics in nine human cell types. Nature (2011) 24.37

A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol (2011) 16.53

Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet (2012) 15.21

The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol (2010) 13.99

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med (2000) 12.34

CpG islands and the regulation of transcription. Genes Dev (2011) 9.50

A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet (2007) 9.47

UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science (2007) 7.90

Epigenetic modifications and human disease. Nat Biotechnol (2010) 7.29

Evaluation of the Infinium Methylation 450K technology. Epigenomics (2011) 4.90

Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood (2003) 4.54

Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol (2011) 4.34

Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci U S A (2008) 4.20

Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell (2012) 3.65

The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet (2013) 3.43

Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet (2012) 3.08

Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. Genome Res (2009) 2.87

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood (2012) 2.82

DNA methylation screening identifies driver epigenetic events of cancer cell survival. Cancer Cell (2012) 2.45

Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia (2009) 2.11

Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation. Genome Res (2008) 2.03

A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Genome Res (2012) 1.92

Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting. Blood (2010) 1.87

Genomic impact of transient low-dose decitabine treatment on primary AML cells. Blood (2013) 1.80

Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia. Blood (2011) 1.74

DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes. Genome Biol (2013) 1.71

Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood (2011) 1.67

Using MACS to identify peaks from ChIP-Seq data. Curr Protoc Bioinformatics (2011) 1.64

DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia. Blood (2009) 1.42

Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia. Cancer Discov (2012) 1.33

Characterizing DNA methylation patterns in pancreatic cancer genome. Mol Oncol (2009) 1.29

Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options. Blood (2009) 1.26

Nuclear hormone receptor co-repressors: structure and function. Mol Cell Endocrinol (2011) 1.23

The DNA methylome of pediatric acute lymphoblastic leukemia. Hum Mol Genet (2009) 1.23

Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia. Blood (2012) 1.20

Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia. J Clin Invest (2013) 1.19

Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer. Semin Cancer Biol (2010) 1.18

Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks. Blood (2011) 1.15

Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia. PLoS One (2011) 1.13

A distinct DNA methylation signature defines pediatric pre-B cell acute lymphoblastic leukemia. Epigenetics (2012) 1.04

Characterization of a novel human endogenous retrovirus, HERV-H/F, expressed in human leukemia cell lines. Virology (2002) 1.01

Integration of high-resolution methylome and transcriptome analyses to dissect epigenomic changes in childhood acute lymphoblastic leukemia. Cancer Res (2013) 0.99

DNA methylation analysis of bone marrow cells at diagnosis of acute lymphoblastic leukemia and at remission. PLoS One (2012) 0.97

Epigenomic alterations in localized and advanced prostate cancer. Neoplasia (2013) 0.96

In epigenetic therapy, less is more. Cell Stem Cell (2012) 0.93

Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol. Eur J Haematol (2013) 0.92

Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genes. Leukemia (2011) 0.92

Digital gene expression profiling of primary acute lymphoblastic leukemia cells. Leukemia (2011) 0.87

Articles by these authors

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23

Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09

Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med (2008) 9.61

Transcriptome and genome sequencing uncovers functional variation in humans. Nature (2013) 8.89

Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66

A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet (2009) 5.75

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48

Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet (2009) 5.32

A genetic variation map for chicken with 2.8 million single-nucleotide polymorphisms. Nature (2004) 5.24

A survey of genetic and epigenetic variation affecting human gene expression. Physiol Genomics (2004) 4.99

Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet (2005) 4.80

Global patterns of cis variation in human cells revealed by high-density allelic expression analysis. Nat Genet (2009) 4.72

Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A (2007) 4.71

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13

Inhibition of proteasome deubiquitinating activity as a new cancer therapy. Nat Med (2011) 4.09

Investigation of the fine structure of European populations with applications to disease association studies. Eur J Hum Genet (2008) 3.65

Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum (2004) 3.57

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

Targeted screening of cis-regulatory variation in human haplotypes. Genome Res (2008) 3.10

Geographical structure and differential natural selection among North European populations. Genome Res (2009) 3.03

Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95. J Clin Oncol (2013) 2.98

Prevalence of t(12;21)[ETV6-RUNX1]-positive cells in healthy neonates. Blood (2010) 2.98

Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet (2011) 2.73

CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70

A high-density SNP-based linkage map of the chicken genome reveals sequence features correlated with recombination rate. Genome Res (2008) 2.70

Survey of allelic expression using EST mining. Genome Res (2005) 2.67

Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat Genet (2009) 2.65

Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med (2012) 2.60

Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood (2009) 2.57

Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease. Am J Hum Genet (2009) 2.56

High-resolution, high-throughput SNP mapping in Drosophila melanogaster. Nat Methods (2008) 2.55

A probabilistic approach for SNP discovery in high-throughput human resequencing data. Genome Res (2009) 2.55

Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Blood (2009) 2.53

Reproducibility of high-throughput mRNA and small RNA sequencing across laboratories. Nat Biotechnol (2013) 2.53

Use of genome-wide association studies for drug repositioning. Nat Biotechnol (2012) 2.51

Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet (2010) 2.47

Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J Immunol (2003) 2.45

Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes (2010) 2.44

An integration of genome-wide association study and gene expression profiling to prioritize the discovery of novel susceptibility Loci for osteoporosis-related traits. PLoS Genet (2010) 2.43

Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum (2005) 2.42

Global analysis of DNA methylation variation in adipose tissue from twins reveals links to disease-associated variants in distal regulatory elements. Am J Hum Genet (2013) 2.40

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet (2013) 2.39

Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med (2005) 2.36

Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlations. Hum Mutat (2009) 2.34

Novel associations between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia. Blood (2011) 2.29

The type I interferon system in systemic lupus erythematosus. Arthritis Rheum (2006) 2.25

Cerebellar mutism: review of the literature. Childs Nerv Syst (2011) 2.22

Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes (2011) 2.21

Population genomics in a disease targeted primary cell model. Genome Res (2009) 2.20

Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum (2003) 2.16

An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet (2007) 2.14

B lymphocytes enhance interferon-α production by plasmacytoid dendritic cells. Arthritis Rheum (2012) 2.09

A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet (2009) 2.09

Sex chromosome evolution and speciation in Ficedula flycatchers. Proc Biol Sci (2003) 2.08

Many QTLs with minor additive effects are associated with a large difference in growth between two selection lines in chickens. Genet Res (2005) 2.07

Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood (2003) 2.03

Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation. Genome Res (2008) 2.03

The relationship between DNA methylation, genetic and expression inter-individual variation in untransformed human fibroblasts. Genome Biol (2014) 2.01

Quantitative evaluation by minisequencing and microarrays reveals accurate multiplexed SNP genotyping of whole genome amplified DNA. Nucleic Acids Res (2003) 1.99

A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Hum Mol Genet (2008) 1.98

Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum Mol Genet (2007) 1.95

The study of eQTL variations by RNA-seq: from SNPs to phenotypes. Trends Genet (2010) 1.94

Homozygous BUB1B mutation and susceptibility to gastrointestinal neoplasia. N Engl J Med (2010) 1.90

Mapping of numerous disease-associated expression polymorphisms in primary peripheral blood CD4+ lymphocytes. Hum Mol Genet (2010) 1.89

Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA. Arthritis Rheum (2006) 1.86

Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease. Circ Cardiovasc Genet (2010) 1.86

Multiple displacement amplification to create a long-lasting source of DNA for genetic studies. Hum Mutat (2006) 1.86

The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. Cancer Res (2007) 1.85

Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med (2009) 1.85

Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. Neurology (2014) 1.85